首页> 外文期刊>American journal of clinical and experimental immunology >Regulatory T cells and regulation of allergic airway disease
【24h】

Regulatory T cells and regulation of allergic airway disease

机译:调节性T细胞和过敏性气道疾病的调节

获取原文
       

摘要

Diseases like asthma have dramatically increased in the last decades. The reasons for the rising prevalence are still controversially discussed. Besides the genetic predisposition a number of different causes are thought to affect the increase of allergies. These include the hygiene hypothesis as well as changes in intestinal microbiota. Allergic airway inflammation is driven by T cells but it has become clear that tolerance and also suppression of allergic inflammation are mediated by so called regulatory T cells (Tregs). Indeed, naturally occurring Treg as well as induced Tregs have been shown to suppress allergic airway disease. In addition, the effectiveness of different therapeutic strategies (e.g. allergen immunotherapy) are mediated via Tregs. In addition, several Treg based approaches have been shown to effectively suppress allergic airway disease in different models. However, more research is needed to explore these potentially interesting approaches for the treatment of human disease.
机译:在过去的几十年中,哮喘等疾病急剧增加。患病率上升的原因仍存在争议。除了遗传易感性外,许多不同的原因也被认为会影响过敏的增加。这些包括卫生假说以及肠道菌群的变化。过敏性气道炎症是由T细胞驱动的,但现在已经清楚,耐受性以及对过敏性炎症的抑制是由所谓的调节性T细胞(Tregs)介导的。实际上,已显示天然存在的Treg以及诱导的Treg可抑制过敏性气道疾病。另外,通过Treg介导不同治疗策略(例如过敏原免疫疗法)的有效性。此外,已显示出几种基于Treg的方法可在不同模型中有效抑制过敏性气道疾病。然而,需要更多的研究来探索这些潜在的有趣的人类疾病治疗方法。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号